Guided by Leaders in Ophthalmology, Oncology, and Rare Diseases
At GLC, we are founded by Prof Andrew Chang, a renowned vitreoretinal surgeon in the Asia-Pacific region with over 30 years of extensive clinical trial experience. Since our beginnings, our team has grown to include a team of medically, clinically, and academically experienced key department heads.
Our CEO, Dr Rober Lin, has extensive experience in oncology therapies and research, helping to guide our team through your research journey. This experience and background cement our foundation in key areas of expertise including but not limited to Ophthalmology, Oncology, and Rare Diseases.
